Nxera Pharma Co.,Ltd. [4565.T]
TOKYO, May 01 (Pulse News Wire) – Nxera Pharma Co., Ltd. (4565.T) reported consolidated results for Q1 FY2026 (ending December 2026).
Revenue was ¥11.3 billion (+69.4% YoY). operating profit was ¥5,495 million.
Net profit was ¥3,043 million. The full-year forecast for the current fiscal year is revenue of ¥11.3 billion (+6.0%).
Financial results — FY2026/12 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥11,256M | +69.4% |
| Operating profit | ¥5,495M | n/a |
| Net profit | ¥3,043M | n/a |
Source: TDNet filing · Figures in millions of yen
🟢 Confidence: High AI-translated content.